Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Tropical Medicine & International Health : TM & IH|August 19, 2007
Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural UgandaCheryl A Liechty, Peter Solberg, Willy Were, et al.
BMJ (Clinical Research Ed.)|November 15, 2011
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness studyJames G Kahn, Elliot Marseille, David Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2012
HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrheaJames D Campbell, David Moore, Richard Degerman, et al.
AIDS Patient Care and Stds|September 10, 2008
Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural UgandaPaul J Weidle, David Moore, Jonathan Mermin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 10, 2008
Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural UgandaKate Buchacz, Paul J Weidle, David Moore, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2007
Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural UgandaFatu Forna, Cheryl A Liechty, Peter Solberg, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|March 10, 2009
Hematologic changes associated with Zidovudine following single-drug substitution from stavudine in a home-based AIDS care program in rural UgandaFatu Forna, David Moore, Jonathan Mermin, et al.
Pageof 3